AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BRAVE BISON GROUP PLC

Foreign Filer Report May 22, 2017

7530_rns_2017-05-22_88451f00-eb7d-4505-831b-8d3b1897683f.html

Foreign Filer Report

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8482F

Brave Bison Group PLC

22 May 2017

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser: Brave Bison Group plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree
Brave Bison Group plc
(d) Is the discloser the offeror or the offeree? OFFEREE
(e) Date position held:

     The latest practicable date prior to the disclosure
19 May 2017
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"
No

2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security: Ordinary Shares of 25p each
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: Nil 0 Nil 0
(2) Cash-settled derivatives: Nil 0 Nil 0
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: Nil 0 Nil 0
TOTAL: Nil 0 Nil 0

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b)        Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists: None
Details, including nature of the rights concerned and relevant percentages: N/A

3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

The directors of Brave Bison Group plc (the "Company") have the following interests in the Company:

Director No. of ordinary shares % of issued share capital
Sir Robin Miller 1,693,243 0.30%
Ashley MacKenzie 23,159,543 4.1%
Close relatives of Ashley MacKenzie* 23,752,363* 4.2%*
Mark Cranmer 800,000 0.14%
Kevin Deeley 1,988,859 0.35%
Paul Marshall - -

* Includes:

-      Kelvin MacKenzie (father) - 22,797,766 (4.0% of issued share capital); and

-      Haydn MacKenzie (brother) - 954,597 (0.2% of issued share capital).

The directors of the Company have the following right to subscribe for the following relevant Company securities:

Name of holder Date of grant Exercise price (pence) Expiry date Number of relevant Company Shares
Ashley MacKenzie 8/2/2016 £0.05 8/2/2019 17,074,309
Kevin Deeley 20/5/2016 £0.05 20/5/2019 7,114,295
Kevin Deeley 13/11/2015 £0.001 13/11/2025 1,379,389
Sir Robin Miller 8/2/2016 £0.05 8/2/2019 1,172,859
Mark Cranmer 8/2/2016 £0.05 8/2/2019 1,422,859

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"
None

(c)        Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions) NO
Supplemental Form 8 (SBL) NO
###### Date of disclosure: 22 May 2017
###### Contact name: Kevin Deeley
###### Telephone number: +44 (0)207 183 4545

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

FEEFLLFLDEFLBBV

Talk to a Data Expert

Have a question? We'll get back to you promptly.